EURECA (EUropeanRElapseCAlprotectin) Study

NACompletedINTERVENTIONAL
Enrollment

225

Participants

Timeline

Start Date

June 2, 2017

Primary Completion Date

January 13, 2020

Study Completion Date

January 13, 2020

Conditions
Inflammatory Bowel Diseases
Interventions
DIAGNOSTIC_TEST

LIAISON Calprotectin

Immunoassay for fecal calprotectin measurement

Trial Locations (3)

Unknown

Centre Hospitalier Universitaire De Nancy (CHU de Nancy) Department Gastroenterology, Nancy

Istituto Clinico Humanitas Centro IBD Diparimento di Gastroenterologia, Milan

Centro Médico Teknon Gastroenterologia Adultos, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

DiaSorin Inc.

INDUSTRY

NCT05168917 - EURECA (EUropeanRElapseCAlprotectin) Study | Biotech Hunter | Biotech Hunter